Cargando…
Cardioprotective effects of 5‐hydroxymethylfurfural mediated by inhibition of L‐type Ca(2+) currents
BACKGROUND AND PURPOSE: The antioxidant 5‐hydroxymethylfurfural (5‐HMF) exerts documented beneficial effects in several experimental pathologies and is currently tested as an antisickling drug in clinical trials. In the present study, we examined the cardiovascular effects of 5‐HMF and elucidated th...
Autores principales: | Wölkart, G, Schrammel, A, Koyani, C N, Scherübel, S, Zorn‐Pauly, K, Malle, E, Pelzmann, B, Andrä, M, Ortner, A, Mayer, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610158/ https://www.ncbi.nlm.nih.gov/pubmed/28768052 http://dx.doi.org/10.1111/bph.13967 |
Ejemplares similares
-
I(f) blocking potency of ivabradine is preserved under elevated endotoxin levels in human atrial myocytes
por: Scheruebel, Susanne, et al.
Publicado: (2014) -
Saxagliptin but Not Sitagliptin Inhibits CaMKII and PKC via DPP9 Inhibition in Cardiomyocytes
por: Koyani, Chintan N., et al.
Publicado: (2018) -
Hypochlorite-Modified LDL Induces Arrhythmia and Contractile Dysfunction in Cardiomyocytes
por: Koyani, Chintan N., et al.
Publicado: (2021) -
Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist
por: Wölkart, G, et al.
Publicado: (2012) -
Investigation of antioxidative effects of a cardioprotective solution in heart tissue
por: Russ, Miriam, et al.
Publicado: (2019)